Cytotheryx is a platform technology company focused on the development of a high-quality, consistent source of primary human hepatocytes (HHCs), or liver cells.
Based in Rochester, Minnesota, Cytotheryx is using innovative technology to increase the supply of available cells for use by pharmaceutical companies, biotechnology companies, and academic research institutions. Primary human hepatocytes are used widely in research, making them vital to continued scientific and therapeutic breakthroughs. However, a limited supply of liver cells prevents ongoing growth.
Cytotheryx is opening doors for how we treat liver disease, develop therapeutics, advance research, and beyond.